Emergence of Resistance to Protease Inhibitor Amprenavir in Human Immunodeficiency Virus Type 1-Infected Patients: Selection of Four Alternative Viral Protease Genotypes and Influence of Viral Susceptibility to Coadministered Reverse Transcriptase Nucleoside Inhibitors

Previous data have indicated that the development of resistance to amprenavir, an inhibitor of the human immunodeficiency virus type 1 protease, is associated with the substitution of valine for isoleucine at residue 50 (I50V) in the viral protease. We present further findings from retrospective gen...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Maguire, Michael, Shortino, Denise, Klein, Astrid, Harris, Wendy, Manohitharajah, Varsha, Tisdale, Margaret, Elston, Robert, Yeo, Jane, Randall, Sharon, Xu, Fan, Parker, Hayley, May, Jackie, Snowden, Wendy
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2002
Matèries:	Antiviral Agents
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127503/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11850255/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.3.731-738.2002
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!